Get the Stockscreener App
12.62
0.16%
-0.02
After Hours:
12.62
Optimizerx Corp stock is traded at $12.62, with a volume of 206.83K.
It is down -0.16% in the last 24 hours and down -6.52% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$12.64
Open:
$12.61
24h Volume:
206.83K
Relative Volume:
0.75
Market Cap:
$233.41M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-15.77
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
-9.47%
1M Performance:
-6.52%
6M Performance:
+127.39%
1Y Performance:
+15.67%
1-Day Range:
$12.56
$13.40
1-Week Range:
$12.51
$14.63
52-Week Range:
$3.78
$15.71
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
12.62 | 233.78M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
284.20 | 46.88B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
56.59 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.00 | 8.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
58.75 | 11.03B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.17B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Bull Of The Day: OptimizeRX (OPRX) - Yahoo Finance
Does OptimizeRx Have a Moat in the Crowded HealthTech Space? - Nasdaq
How did Optimizerx's revenue and expenses trend in Q4 2024? - AInvest
What institutional investors are buying OptimizeRx Corporation stockReal Time Watchlist With Low Risk - jammulinksnews.com
Is OptimizeRx Corporation Stock a Good Fit for Conservative InvestorsAnnual Market Behavior and Sector Summary - Newser
Advanced analytics toolkit walkthrough for OptimizeRx CorporationFree Smart Trade Plans With Risk Protection - Newser
What MACD and RSI say about OptimizeRx CorporationRisk/Reward Optimization Entry Point Analysis - Newser
Former OptimizeRX CEO William Febbo joins Paynela’s board By Investing.com - Investing.com South Africa
Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors - Stock Titan
Detecting price anomalies in OptimizeRx Corporation with AIPattern Recognition Based Market Move Prediction - Newser
OptimizeRx Corp. (NASDAQ:OPRX) Shares Sold by Royce & Associates LP - MarketBeat
OptimizeRx Corporation’s Price Action Aligns with Quant SignalsChart Driven High Reward Trading Setup Presented - metal.it
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum? - MSN
OptimizeRx Corporation Hits Price Floor — Bounce IncomingMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Perkins Capital Management Inc. Has $378,000 Holdings in OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
How many analysts rate OptimizeRx Corporation as a “Buy”Phenomenal capital gains - jammulinksnews.com
What catalysts could drive OptimizeRx Corporation stock higher in 2025Discover high-growth stocks for your portfolio - jammulinksnews.com
Should I hold or sell OptimizeRx Corporation stock in 2025High-octane investment opportunities await - jammulinksnews.com
Is OptimizeRx Corporation stock overvalued or undervaluedInvest smarter with expert stock recommendations - jammulinksnews.com
OptimizeRx Corporation Company’s Quarterly Earnings Growth: What the Numbers SayShort Squeeze Radar - metal.it
OptimizeRx Corporation Earnings Report Breakdown: What Investors Should KnowFree Premium Stock Market Reports - Newser
OptimizeRx Corp. (NASDAQ:OPRX) Receives $10.81 Average Price Target from Brokerages - MarketBeat
Optimizerx 15min Chart Sees KDJ Golden Cross, Bullish Marubozu Signal. - AInvest
Analysts Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $10.81 - Defense World
What analysts say about OptimizeRx Corporation stockExplosive market performance - PrintWeekIndia
Is OptimizeRx Corporation a good long term investmentFree Capital Allocation Plans - jammulinksnews.com
How OptimizeRx Corporation stock performs during market volatilityStrong Buy Recommendations - Newser
Best Growth Stocks to Buy for July 22nd - TradingView
OptimizeRx Corporation Stock Analysis and ForecastFree High-Return Strategy Alerts - jammulinksnews.com
What makes OptimizeRx Corporation stock price move sharplyProven High Yield Signals - Newser
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - MSN
OptimizeRx: Stock Could Rise As Profitability Is Achieved - Seeking Alpha
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - The Globe and Mail
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET - The Globe and Mail
OptimizeRx Corp. to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 - Quiver Quantitative
Capstone Lands Major Clean Energy Win: 90% Government-Funded Microturbine Project Shows Long-Term Success - Stock Titan
OPRX Vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - Barchart.com
Why OptimizeRx Corporation stock attracts strong analyst attentionFree Risk Assessment Services - Newser
Calamos Advisors LLC Invests $289,000 in OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
3.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):